The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: Comparison of American and Japanese gastric cancer patients

Annals of Surgical Oncology

Volumn 16, Issue 3, 2009, Pages 609-613

  Fukagawa, T ^a   Sasako, M ^a   Shimoda, T ^a   Sano, T ^a   Katai, H ^a   Saka, M ^a   Mann, G B ^b   Karpeh, M ^c   Coit, D G ^d   Brennan, M F ^d  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMERICAN; ARTICLE; CANCER GRADING; CANCER SURGERY; CELL ISOLATION; CONTROLLED STUDY; ETHNIC GROUP; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPANESE; LYMPH NODE; MAJOR CLINICAL STUDY; PROGNOSIS; RACE DIFFERENCE; STOMACH CARCINOMA; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; JAPAN; KERATINS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 60449086428     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0290-7     Document Type: Article

References (36)

1. T Sano M Sasako T Kinoshita K Maruyama 1993 Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature Cancer 72 3174 3178
2. N Hayashi H Arakawa H Nagase A Yanagisawa Y Kato H Ohta 1994 Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method Cancer Res 54 3853 3856
3. P Hermanek RV Hutter LH Sobin C Wittekind 1999 International Union Against Cancer. Classification of isolated tumor cells and micrometastasis Cancer 86 2668 2673
4. LH Sobin 2003 TNM, sixth edition: new developments in general concepts and rules Semin Surg Oncol 21 19 22
5. JW Fielding 1989 Gastric cancer: different diseases Br J Surg 76 1227
6. T Fukagawa M Sasako GB Mann T Sano H Katai K Maruyama 2001 Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma Cancer 92 753 760
7. Hamilton SR, Aaltonen LA. WHO classification of tumors: pathology and genetics of the digestive system. Lyon, France: IARC Press; 2000.
8. JR Siewert R Kestlmeier R Busch K Böttcher JD Roder J Müller 1996 Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases Br J Surg 83 1144 1147
9. E Lee Y Chae I Kim J Choi B Yeom AS Leong 2002 Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma Cancer 94 2867 2873
10. S Ishigami S Natsugoe K Tokuda A Nakajo H Higashi T Watanabe 2003 Clinical impact of micrometastasis of the lymph node in gastric cancer Am Surg 69 573 577
11. J Cai M Ikeguchi M Maeta N Kaibara T Sakatani 1999 Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer Gastric Cancer 2 95 100
12. HJ Choi YK Kim YH Kim SS Kim SH Hong 2002 Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma Ann Surg Oncol 9 13 19
13. P Morgagni L Saragoni E Scarpi PS Zattini A Zaccaroni D Morgagni 2003 Lymph node micrometastases in early gastric cancer and their impact on prognosis World J Surg 27 558 561
14. FS Doekhie WE Mesker JH van Krieken NF Kok HH Hartgrink EK Kranenbarg 2005 Clinical relevance of occult tumor cells in lymph nodes from gastric cancer patients Am J Surg Pathol 29 1135 1144
15. Y Kikuchi A Tsuchiya Y Ando T Yoshida S Takenosita 1999 Immunohistochemical detection of lymph node microinvolvement in node-negative gastric cancer Gastric Cancer 2 173 178
16. T Yoshikawa A Tsuburaya O Kobayashi M Sairenji H Motohashi Y Noguchi 2003 Peritoneal cytology in patients with gastric cancer exposed to the serosa-a proposed new classification based on the local and distant cytology Hepatogastroenterology 50 1183 1186
17. G Cserni S Bianchi W Boecker T Decker M Lacerda F Rank 2005 Improving the reproducibility of diagnosing micrometastases and isolated tumor cells Cancer 103 358 367
18. DL Weaver 2003 Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am J Surg Pathol 27 842 845
19. L Holmgren MS O'Reilly J Folkman 1995 Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1 149 153
20. P Scheunemann JR Izbicki K Pantel 1999 Tumorigenic potential of apparently tumor-free lymph nodes New Engl J Med 340 1687
21. GC O'Sullivan JK Collins J Kelly J Morgan M Madden F Shanahan 1997 Micrometastases: marker of metastatic potential or evidence of residual disease? Gut 40 512 515
22. MS Karpeh L Leon D Klimstra MF Brennan 2000 Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1, 038 patients Ann Surg 232 362 371
23. S Natsugoe S Nakashima M Matsumoto A Nakajo F Miyazono F Kijima 1999 Paraaortic lymph node micrometastasis and tumor cell microinvolvement in advanced gastric carcinoma Gastric Cancer 2 179 185
24. Y Yonemura Y Endo I Hayashi T Kawamura HY Yun E Bandou 2007 Proliferative activity of micrometastases in the lymph nodes of patients with gastric cancer Br J Surg 94 731 736
25. K Pantel RJ Cote O Fodstad 1999 Detection and clinical importance of micrometastatic disease J Natl Cancer Inst 91 1113 1124
26. SY Wong RO Hynes 2006 Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5 812 817
27. JJ Bonenkamp J Hermans M Sasako CJ van de Velde K Welvaart I Songun 1999 Extended lymph-node dissection for gastric cancer New Engl J Med 340 908 914
28. JS Macdonald SR Smalley J Benedetti SA Hundahl NC Estes GN Stemmermann 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730
29. S Sakuramoto M Sasako T Yamaguchi T Kinoshita M Fujii A Nashimoto 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820
30. Y Noguchi T Imada A Matsumoto DG Coit MF Brennan 1989 Radical surgery for gastric cancer. A review of the Japanese experience Cancer 64 2053 2062
31. MF Brennan 1989 Radical surgery for gastric cancer. A review of the Japanese experience Cancer 64 2063
32. PA Davis T Sano 2001 The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol 40 77 94
33. SA Hundahl GN Stemmermann A Oishi 1996 Racial factors cannot explain superior Japanese outcomes in stomach cancer Arch Surg 131 170 175
34. AM Bunt J Hermans VT Smit CJ van de Velde GJ Fleuren JA Bruijn 1995 Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries J Clin Oncol 13 19 25
35. P McCulloch T Taggart A Ochiai G O'Dowd J Nash M Sasako 1997 c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan Eur J Surg Oncol 23 304 309
36. CP Theuer BS Campbell DJ Peel F Lin P Carpenter A Ziogas 2002 Microsatellite instability in Japanese vs European American patients with gastric cancer Arch Surg 137 960 965 discussion 965